Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy.
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001854:Bone Marrow Cells; D002455:Cell Division; D003561:Cytarabine / Q000627:therapeutic use; D006413:Hematopoietic System / Q000503:physiopathology; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy* / Q000503:physiopathology; D007939:Leukemia L1210 / Q000188:drug therapy / Q000503:physiopathology; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000503:physiopathology; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000503:physiopathology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000503:physiopathology; D007962:Leukocytes; D008214:Lymphocytes; D051379:Mice; D009368:Neoplasm Transplantation; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D003561:Cytarabine; D014316:Tritium; D013936:Thymidine